Related Experiment Videos
[Inborn and acquired von Willebrand disease].
R Schneppenheim1, M Barthels, U Budde
1Klinik für Pädiatrische Hämatologie und Onkologie, Universitäts-Klinikum Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg. schneppenheim@uke.uni-hamburg.de
Hamostaseologie
|January 6, 2006
Summary
Von Willebrand disease (VWD) presents with significant heterogeneity due to varying quantitative and qualitative differences. This review covers essential diagnostic and therapeutic facts for VWD management.
Area of Science:
- Hematology
- Genetics
- Internal Medicine
Context:
- Von Willebrand disease (VWD) exhibits significant heterogeneity, a characteristic noted since its initial description.
- Understanding the basis of phenotypic variation is crucial for effective VWD management.
Purpose:
- To present clinically relevant information on the diagnosis and therapy of Von Willebrand disease and syndrome.
- To provide practitioners with essential facts for managing VWD.
Summary:
- VWD heterogeneity stems from quantitative and qualitative/functional differences across its types and subtypes.
- This review synthesizes key diagnostic criteria and therapeutic strategies for VWD.
- Focuses on practical aspects relevant to clinical practitioners.
Impact:
- Aims to improve the diagnostic accuracy and therapeutic outcomes for patients with VWD.
- Enhances clinical decision-making for healthcare providers managing VWD.
- Contributes to a better understanding of VWD's complex nature.